BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21535172)

  • 1. Progressive macular hypomelanosis, excellent response with narrow-band ultraviolet B phototherapy.
    Montero LC; Belinchón I; Toledo F; Betlloch I
    Photodermatol Photoimmunol Photomed; 2011 Jun; 27(3):162-3. PubMed ID: 21535172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the clinical efficacy of NBUVB and NBUVB with benzoyl peroxide/clindamycin in progressive macular hypomelanosis.
    Sim JH; Lee DJ; Lee JS; Kim YC
    J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1318-23. PubMed ID: 21349111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
    Relyveld GN; Kingswijk MM; Reitsma JB; Menke HE; Bos JD; Westerhof W
    J Am Acad Dermatol; 2006 Nov; 55(5):836-43. PubMed ID: 17052490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of progressive macular hypomelanosis with narrow-band ultraviolet B phototherapy.
    Kwah YC; Chong WS; Thiam-Seng Theng C; Goh BK
    Photodermatol Photoimmunol Photomed; 2010 Jun; 26(3):153-5. PubMed ID: 20584255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and relapse rates of different treatment modalities for progressive macular hypomelanosis.
    Thng ST; Long VS; Chuah SY; Tan VW
    Indian J Dermatol Venereol Leprol; 2016; 82(6):673-676. PubMed ID: 27212282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive macular hypomelanosis successfully treated with topical clindamycin and benzoyl peroxide].
    Echeverría B; Botella-Estrada R; Escutia B; Guillén C
    Actas Dermosifiliogr; 2010 Jul; 101(6):565-7. PubMed ID: 20738984
    [No Abstract]   [Full Text] [Related]  

  • 8. Progressive macular hypomelanosis: an overview.
    Relyveld GN; Menke HE; Westerhof W
    Am J Clin Dermatol; 2007; 8(1):13-9. PubMed ID: 17298102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive macular hypomelanosis.
    Elmariah SB; Kundu RV
    J Drugs Dermatol; 2011 May; 10(5):502-6. PubMed ID: 21533296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of progressive macular hypomelanosis treated with 1% topical clindamycin lotion and narrow-band ultraviolet B.
    Erpolat S; Gorpelioglu C; Sarifakioglu E
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):277-8. PubMed ID: 20831700
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of progressive macular hypomelanosis successfully treated with benzoyl peroxide plus narrow-band UVB.
    Wu XG; Xu AE; Luo XY; Song XZ
    J Dermatolog Treat; 2010 Nov; 21(6):367-8. PubMed ID: 20524876
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive macular hypomelanosis in a 16-year old.
    Perman M; Sheth P; Lucky AW
    Pediatr Dermatol; 2008; 25(1):63-5. PubMed ID: 18304157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial.
    Karsai S; Schmitt L; Raulin C
    Br J Dermatol; 2010 Aug; 163(2):395-401. PubMed ID: 20394631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of progressive macular hypomelanosis.
    Leonard N; Krueger S; Rashighi M
    Dermatol Reports; 2020 Sep; 12(2):8509. PubMed ID: 33408831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrowband UVB treatment of progressive macular hypomelanosis.
    Kim MB; Kim GW; Cho HH; Park HJ; Kim HS; Kim SH; Kim BS; Ko HC
    J Am Acad Dermatol; 2012 Apr; 66(4):598-605. PubMed ID: 22005073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of lymecycline and benzoyl peroxide for the treatment of progressive macular hypomelanosis: a prospective study.
    Cavalcanti SM; Querino MC; Magalhães V; França ER; Magalhães M; Alencar E
    An Bras Dermatol; 2011; 86(4):813-4. PubMed ID: 21987158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single blind randomized clinical study: the efficacy of isotretinoin plus narrow band ultraviolet B in the treatment of psoriasis vulgaris.
    Mortazavi H; Khezri S; Hosseini H; Khezri F; Vasigh M
    Photodermatol Photoimmunol Photomed; 2011 Jun; 27(3):159-61. PubMed ID: 21535171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Sheehan-Dare R; Layton A
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A
    J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive macular hypomelanosis arising in a young African American woman in association with pregnancy and a toxic nodular goiter.
    Tierney EP; Hamzavi I
    J Drugs Dermatol; 2010 Apr; 9(4):393-7. PubMed ID: 20514800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.